KalVista Pharmaceuticals, Inc. - KALV
Ownership (Schedule 13D / 13G) · latest 50 filings
· Back to all files
Visible: 0
| Filed | Form | Reporting person | Percent | Shares | SEC |
|---|---|---|---|---|---|
| Jan 13, 2026 | SCHEDULE 13G/A | Point72 Asset Management, L.P. | 5.5% | 2,781,902 | View |
| Jan 13, 2026 | SCHEDULE 13G/A | Point72 Capital Advisors, Inc. | 5.5% | 2,781,902 | View |
| Jan 13, 2026 | SCHEDULE 13G/A | Steven A. Cohen | 5.5% | 2,781,902 | View |
| Jan 12, 2026 | SCHEDULE 13G | Point72 Asset Management, L.P. | 4.9% | 2,523,493 | View |
| Jan 12, 2026 | SCHEDULE 13G | Point72 Capital Advisors, Inc. | 4.9% | 2,523,493 | View |
| Jan 12, 2026 | SCHEDULE 13G | Steven A. Cohen | 4.9% | 2,523,493 | View |
| Dec 30, 2025 | SCHEDULE 13G/A | Integrated Core Strategies (US) LLC | 5.1% | 2,588,344 | View |
| Dec 30, 2025 | SCHEDULE 13G/A | Millennium Management LLC | 5.9% | 2,963,699 | View |
| Dec 30, 2025 | SCHEDULE 13G/A | Millennium Group Management LLC | 5.9% | 2,963,699 | View |
| Dec 30, 2025 | SCHEDULE 13G/A | Israel A. Englander | 5.9% | 2,963,699 | View |
| Nov 14, 2025 | SCHEDULE 13G/A | Vestal Point Capital, LP | 1.5% | 750,000 | View |
| Nov 14, 2025 | SCHEDULE 13G/A | Ryan Wilder | 1.5% | 750,000 | View |
| Nov 10, 2025 | SCHEDULE 13G | Millennium Management LLC | 5.0% | 2,531,010 | View |
| Nov 10, 2025 | SCHEDULE 13G | Millennium Group Management LLC | 5.0% | 2,531,010 | View |
| Nov 10, 2025 | SCHEDULE 13G | Israel A. Englander | 5.0% | 2,531,010 | View |
| Nov 04, 2025 | SCHEDULE 13D/A | — | — | — | View |
Percent = "% of class represented by amount beneficially owned" for this reporting person in the filed 13D/13G.
Shares = reported beneficial ownership amount for the same row (not portfolio shares from 13F).
Amendments (/A) can repeat the same holder over time, so rows should not be summed.
Extraction is best-effort from filing text and can be missing or noisy; verify exact figures via the SEC link in each row.